Ascendis Pharma A/S (ASND)
237.50
+0.78
(+0.33%)
USD |
NASDAQ |
Sep 21, 16:00
237.30
-0.20
(-0.08%)
After-Hours: 20:00
Ascendis Pharma Total Return Price : 237.50 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 236.72 |
| September 17, 2026 | 239.04 |
| September 16, 2026 | 247.69 |
| September 15, 2026 | 239.77 |
| September 14, 2026 | 264.92 |
| September 11, 2026 | 263.52 |
| September 10, 2026 | 261.23 |
| September 09, 2026 | 260.81 |
| September 08, 2026 | 270.09 |
| September 04, 2026 | 270.56 |
| September 03, 2026 | 271.12 |
| September 02, 2026 | 267.31 |
| September 01, 2026 | 260.25 |
| August 31, 2026 | 263.04 |
| August 28, 2026 | 247.91 |
| August 27, 2026 | 249.36 |
| August 26, 2026 | 250.25 |
| August 25, 2026 | 252.99 |
| August 24, 2026 | 251.95 |
| August 21, 2026 | 253.29 |
| August 20, 2026 | 254.81 |
| August 19, 2026 | 259.62 |
| August 18, 2026 | 248.85 |
| August 17, 2026 | 247.40 |
| August 14, 2026 | 248.50 |
| Date | Value |
|---|---|
| August 13, 2026 | 246.23 |
| August 12, 2026 | 255.46 |
| August 11, 2026 | 254.57 |
| August 10, 2026 | 255.62 |
| August 07, 2026 | 255.41 |
| August 06, 2026 | 249.85 |
| August 05, 2026 | 244.20 |
| August 04, 2026 | 244.59 |
| August 03, 2026 | 243.45 |
| July 31, 2026 | 243.91 |
| July 30, 2026 | 251.07 |
| July 29, 2026 | 252.05 |
| July 28, 2026 | 254.44 |
| July 27, 2026 | 253.42 |
| July 24, 2026 | 253.86 |
| July 23, 2026 | 252.66 |
| July 22, 2026 | 251.93 |
| July 21, 2026 | 255.20 |
| July 20, 2026 | 251.76 |
| July 17, 2026 | 261.00 |
| July 16, 2026 | 259.80 |
| July 15, 2026 | 268.57 |
| July 14, 2026 | 265.57 |
| July 13, 2026 | 265.22 |
| July 10, 2026 | 270.45 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 64.04 |
| Novo Nordisk A/S | 39.81 |
| Evaxion AS | 3.21 |
| Genmab A/S | 34.68 |
| Zealand Pharma A/S | 43.00 |